MAIA BIOTECHNOLOGY INC (MAIA) Stock Income Statement
NYSEARCA:MAIA - US5526411021 - Common Stock
1.58 USD
+0.05 (+3.27%)
1.6 USD
+0.02 (+1.27%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Minority Interest Expense | N/A | N/A | N/A | 0.00 | 74.30K | |||
| Operating Expenses | 19.78M | 16.96M | 20.18M | 16.18M | 7.79M | |||
| Research and Development | 11.94M | 10.01M | 11.11M | 8.93M | 3.50M | |||
| Selling, General, and Administrative Expenses | 7.84M | 6.95M | 9.07M | 7.24M | 4.29M | |||
| Operating Income | -19.78M | -16.96M | -20.18M | -16.18M | -7.79M | |||
| Interest Income/Expense | 347.70K | 318.30K | 27.60K | -5.10K | -1.03M | |||
| Other Income/Expense | 3.26M | -6.62M | 381.90K | 412.00K | -1.50M | |||
| Non Recurring Items | N/A | N/A | N/A | 0.00 | -2.26M | |||
| Income Before Taxes | -16.17M | -23.25M | -19.77M | -15.77M | -12.58M | |||
| Net Income | -16.17M | -23.25M | -19.77M | -16.22M | -12.50M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.60 | -1.05 | -1.49 | -1.75 | -1.18 | |||
| Non GAAP EPS | -0.57 | -1.09 | -1.49 | N/A | N/A | |||
| Statistics | ||||||||
All data in USD